NO20044568L - Fremgangsmate for inhibering av atrofi eller for behandling eller forhindring av atrofi-relaterte symptomer i kvinner - Google Patents
Fremgangsmate for inhibering av atrofi eller for behandling eller forhindring av atrofi-relaterte symptomer i kvinnerInfo
- Publication number
- NO20044568L NO20044568L NO20044568A NO20044568A NO20044568L NO 20044568 L NO20044568 L NO 20044568L NO 20044568 A NO20044568 A NO 20044568A NO 20044568 A NO20044568 A NO 20044568A NO 20044568 L NO20044568 L NO 20044568L
- Authority
- NO
- Norway
- Prior art keywords
- atrophy
- women
- inhibition
- prevention
- procedure
- Prior art date
Links
- 206010003694 Atrophy Diseases 0.000 title abstract 3
- 230000037444 atrophy Effects 0.000 title abstract 2
- 208000024891 symptom Diseases 0.000 title abstract 2
- 230000005764 inhibitory process Effects 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 206010067994 Mucosal atrophy Diseases 0.000 abstract 1
- 206010040799 Skin atrophy Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Medicinal Preparation (AREA)
Abstract
Det beskrives en fremgangsmåte for hemning av hudatrofi eller epitelial eller mukosal atrofi hos kvinner eller en fremgangsmåte for behandling eller forebygging av symptomer beslektet med nevnte atrofi, nevnte fremgangsmåte omfatter administrering til kvinnen av en effektiv mengde av forbindelsen med formel (I) eller en geometrisk isomer, en stereoisomer, et farmasøytisk akseptabelt salt, en ester derav eller en metabolitt derav.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38590402P | 2002-06-06 | 2002-06-06 | |
PCT/FI2003/000369 WO2003103649A1 (en) | 2002-06-06 | 2003-05-14 | Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20044568L true NO20044568L (no) | 2004-12-22 |
NO334090B1 NO334090B1 (no) | 2013-12-09 |
Family
ID=29736123
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20044568A NO334090B1 (no) | 2002-06-06 | 2004-10-22 | Anvendelse av toremifenforbindelser for fremstilling av en farmasøytisk sammensetning for hemming av urogenital atrofi hos kvinner |
NO20131189A NO336612B1 (no) | 2002-06-06 | 2013-09-04 | Anvendelse av en forbindelse for fremstilling av en farmasøytisk sammensetning for hemming av urininkontinens i en kvinne |
NO20150487A NO339194B1 (no) | 2002-06-06 | 2015-04-22 | Anvendelse av en forbindelse for fremstilling av en farmasøytisk sammensetning for hemming av urinveisinfeksjon hos en kvinne |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20131189A NO336612B1 (no) | 2002-06-06 | 2013-09-04 | Anvendelse av en forbindelse for fremstilling av en farmasøytisk sammensetning for hemming av urininkontinens i en kvinne |
NO20150487A NO339194B1 (no) | 2002-06-06 | 2015-04-22 | Anvendelse av en forbindelse for fremstilling av en farmasøytisk sammensetning for hemming av urinveisinfeksjon hos en kvinne |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1509215B1 (no) |
JP (1) | JP4362442B2 (no) |
KR (1) | KR100991157B1 (no) |
CN (2) | CN101406464A (no) |
AT (1) | ATE344025T1 (no) |
AU (1) | AU2003227790B2 (no) |
BR (1) | BR0311613A (no) |
CA (1) | CA2484542C (no) |
CY (1) | CY1105787T1 (no) |
DE (1) | DE60309465T2 (no) |
DK (1) | DK1509215T3 (no) |
ES (1) | ES2270025T3 (no) |
HR (1) | HRP20041150B1 (no) |
IL (1) | IL164528A (no) |
MX (1) | MXPA04012220A (no) |
NO (3) | NO334090B1 (no) |
NZ (1) | NZ536118A (no) |
PL (1) | PL214242B1 (no) |
PT (1) | PT1509215E (no) |
RU (1) | RU2317816C2 (no) |
SI (1) | SI1509215T1 (no) |
UA (1) | UA79797C2 (no) |
WO (1) | WO2003103649A1 (no) |
ZA (1) | ZA200408321B (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8236861B2 (en) * | 2004-02-13 | 2012-08-07 | Hormos Medical Corporation | Method for enhancing the bioavailablity of ospemifene |
US8642079B2 (en) | 2004-02-23 | 2014-02-04 | Hormos Medical Corporation | Solid formulations of ospemifene |
US8758821B2 (en) | 2004-05-04 | 2014-06-24 | Hormos Medical Ltd. | Oral formulations of ospemifene |
SI2275098T1 (sl) | 2004-05-04 | 2012-12-31 | Hormos Medical Ltd. | Nove oralne formulacije ospemifena |
KR20090029237A (ko) | 2006-06-02 | 2009-03-20 | 피어 트리 파머슈티칼스 인코포레이티드 | 위축성 질염을 치료하는 방법 |
US7504530B2 (en) | 2007-02-14 | 2009-03-17 | Hormos Medical Ltd. | Methods for the preparation of fispemifene from ospemifene |
ES2590262T3 (es) | 2007-02-14 | 2016-11-21 | Hormos Medical Ltd. | Método para la preparación de derivados de trifenilbuteno con valor terapéutico |
WO2014060639A1 (en) | 2012-10-19 | 2014-04-24 | Fermion Oy | A process for the preparation of ospemifene |
KR102052133B1 (ko) | 2017-08-10 | 2019-12-05 | 고려대학교 산학협력단 | 당 부가된 오스페미펜, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5352699A (en) * | 1992-04-30 | 1994-10-04 | University Of Massachusetts Medical Center | Use of retinioc acid to treat vaginal atrophy |
US5461064A (en) * | 1993-12-21 | 1995-10-24 | Eli Lilly And Company | Methods of inhibiting atrophy of the skin and vagina |
US5747059A (en) * | 1996-01-11 | 1998-05-05 | Novo Nordisk A/S | Atrophy of skin/mucous membrane |
WO2001054699A1 (en) * | 2000-01-28 | 2001-08-02 | Endorecherche, Inc. | Selective estrogen receptor modulators in combination with estrogens |
US20010034340A1 (en) * | 2000-03-20 | 2001-10-25 | American Home Products Corporation | Hormone replacement therapy |
US6245819B1 (en) * | 2000-07-21 | 2001-06-12 | Hormos Medical Oy, Ltd. | Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause |
-
2003
- 2003-05-14 UA UAA200500144A patent/UA79797C2/uk unknown
- 2003-05-14 WO PCT/FI2003/000369 patent/WO2003103649A1/en active IP Right Grant
- 2003-05-14 AU AU2003227790A patent/AU2003227790B2/en not_active Expired
- 2003-05-14 JP JP2004510768A patent/JP4362442B2/ja not_active Expired - Lifetime
- 2003-05-14 CN CNA2008101733358A patent/CN101406464A/zh active Pending
- 2003-05-14 DE DE60309465T patent/DE60309465T2/de not_active Expired - Lifetime
- 2003-05-14 NZ NZ536118A patent/NZ536118A/en not_active IP Right Cessation
- 2003-05-14 RU RU2004138571/14A patent/RU2317816C2/ru active
- 2003-05-14 AT AT03725238T patent/ATE344025T1/de active
- 2003-05-14 MX MXPA04012220A patent/MXPA04012220A/es active IP Right Grant
- 2003-05-14 ES ES03725238T patent/ES2270025T3/es not_active Expired - Lifetime
- 2003-05-14 PL PL372758A patent/PL214242B1/pl unknown
- 2003-05-14 SI SI200330601T patent/SI1509215T1/sl unknown
- 2003-05-14 BR BR0311613-1A patent/BR0311613A/pt not_active Application Discontinuation
- 2003-05-14 CN CNB038128780A patent/CN100448437C/zh not_active Expired - Lifetime
- 2003-05-14 DK DK03725238T patent/DK1509215T3/da active
- 2003-05-14 EP EP03725238A patent/EP1509215B1/en not_active Expired - Lifetime
- 2003-05-14 PT PT03725238T patent/PT1509215E/pt unknown
- 2003-05-14 KR KR1020047019843A patent/KR100991157B1/ko active IP Right Grant
- 2003-05-14 CA CA2484542A patent/CA2484542C/en not_active Expired - Lifetime
-
2004
- 2004-10-12 IL IL164528A patent/IL164528A/en active IP Right Grant
- 2004-10-14 ZA ZA200408321A patent/ZA200408321B/en unknown
- 2004-10-22 NO NO20044568A patent/NO334090B1/no not_active IP Right Cessation
- 2004-12-02 HR HR20041150A patent/HRP20041150B1/xx not_active IP Right Cessation
-
2006
- 2006-11-15 CY CY20061101664T patent/CY1105787T1/el unknown
-
2013
- 2013-09-04 NO NO20131189A patent/NO336612B1/no not_active IP Right Cessation
-
2015
- 2015-04-22 NO NO20150487A patent/NO339194B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200300031A (et) | Klimakteersete häirete ravimeetod naistel menopausi ajal või järel | |
TW200420549A (en) | Thiazole derivatives | |
WO2001081312A3 (en) | Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore | |
ATE539749T1 (de) | Dextromethorphan für die behandlung von akne | |
NO20044568L (no) | Fremgangsmate for inhibering av atrofi eller for behandling eller forhindring av atrofi-relaterte symptomer i kvinner | |
IS7315A (is) | Útskipt díketópíperasín sem oxýtósínmótlyf | |
IL159241A0 (en) | Use of branched-chain fatty acids and derivatives thereof for the treatment of pain | |
NO20061999L (no) | Anvendelse av syliske anabaenopeptin-type peptider for behandling av en tilstand hvor inhibering av karboksypeptidase U er fordelaktig, nye anabaenopeptin-derivater og mellomprodukter derav | |
WO2002056837A3 (en) | Inhibition of protein-phosphatases for the treatment of heart failure | |
RU2008143055A (ru) | Ингибиторы ренина, предназначенные для гипертензии | |
DE60004996D1 (de) | Aminotetralin derivate zur therapie der kardiovaskulären erkrankungen | |
HK1080768A1 (en) | Use of epothilone derivatives for the treatment ofhyperparathyroidism | |
WO2004064761A3 (en) | Therapeutically active compounds | |
DK1042297T3 (da) | Carboxylsyresubstituerede heterocykliske forbindelser som metalloproteinaseinhibitorer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |